Active Awards Portfolio Dashboard

It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards

Disease Cell Typesort descending Therapeutic or Technology Institution Stage Project Objective Details
HIV/AIDS Personalized cell therapy COH
IND
HIV/AIDS Adult Stem Cell Gene editing tools USC
Tool/Resources/Bottleneck
Blood Disorders Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Kidney Failure Adult Stem Cell Biologic Humacyte
Clinical Trial, Phase 3
Blood Disorders Adult Stem Cell Cell processing & handling UCSF
Tool/Resources/Bottleneck
Cancer Adult Stem Cell Personalized cell therapy UCLA
Pre-IND/IDE or Equivalent
Blood Disorders,
Immune Disease
Adult Stem Cell Gene-modified, personalized cell therapy Stanford
Development Candidate
Type 1 diabetes Adult Stem Cell Personalized cell therapy Caladrius Biosciences
Clinical Trial, Phase 2
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Development Candidate, Proof of Concept
Beta Thalassemia,
Sickle Cell Disease
Adult Stem Cell Diagnostic Test CHORI
Regulated Lab Test, Ready for Validation
Amyotrophic Lateral Sclerosis Adult Stem Cell Gene-modified, donor cell therapy Cedars-Sinai
Clinical Trial, Phase 1 or Phase 1/2
Immune Disease,
Severe Combined Immunodeficiency, X-linked (X-SCID)
Adult Stem Cell Antibody Stanford
Clinical Trial, Phase 1 or Phase 1/2
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Leukemia, Acute Myeloid (AML) Adult Stem Cell Gene-modified, personalized cell therapy Loma Linda University
Proof of Concept
Liver Disease Adult Stem Cell Donor cell therapy Stanford
Development Candidate
Parkinson's Disease Adult Stem Cell Gene-modified, donor cell therapy UCSF
IND
Immune Disease,
Severe Combined Immunodeficiency, X-linked (X-SCID)
Adult Stem Cell Gene-modified, personalized cell therapy St. Jude
Clinical Trial, Phase 1 or Phase 1/2
Melanoma,
Skin cancer
Adult Stem Cell Gene-modified, personalized cell therapy UCLA
Clinical Trial, Phase 1 or Phase 1/2
Hearing Loss Adult Stem Cell Protein/peptide therapy Stanford
Development Candidate, Proof of Concept
Arthritis,
Osteoarthritis
Adult Stem Cell Small molecule therapy Calibr
Clinical Trial, Phase 1 or Phase 1/2
Spinal Cord Injury Adult Stem Cell Donor cell therapy UC Irvine
Development Candidate
Osteonecrosis Adult Stem Cell Small molecule therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Blood Cancer,
Bone Marrow Transplant and Viral Infection
Adult Stem Cell Donor cell therapy CHLA
Clinical Trial, Phase 1 or Phase 1/2
Intestinal Disease,
Neurological Disorders
Adult Stem Cell Specific Cell Type Derivation Stanford
Tool/Resources/Bottleneck
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
IND
Multiple Myeloma Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics, Inc.
Clinical Trial, Phase 1 or Phase 1/2
Spina Bifida Adult Stem Cell Donor cell therapy UC Davis
Pre-IND/IDE or Equivalent
Bone or Cartilage Disease Adult Stem Cell Donor cell therapy UCLA
Proof of Concept
Autism Adult Stem Cell Gene-modified, donor cell therapy UC Davis
Development Candidate, Proof of Concept
Prostate Cancer Adult Stem Cell Gene-modified, personalized cell therapy Poseida Therapeutics, Inc.
IND
Skin Disease Adult Stem Cell Personalized cell therapy UC Davis
Proof of Concept
Diabetic Wounds,
Skin Disease
Adult Stem Cell Donor cell therapy UC Davis
Pre-IND/IDE or Equivalent
Kidney Failure Adult Stem Cell Donor cell therapy Medeor Therapeutics
Clinical Trial, Phase 3
Brain Cancer Adult Stem Cell Gene-modified, personalized cell therapy UCSF
Development Candidate, Proof of Concept
Skeletal/Smooth Muscle disorders Adult Stem Cell Protein/peptide therapy Stanford
Research Insights
Intestinal Disease Adult Stem Cell Personalized cell therapy CHLA
Development Candidate, Proof of Concept
Age-related macular degeneration Adult Stem Cell Donor cell therapy Stanford
Pre-IND/IDE or Equivalent
Hemophilia A Adult Stem Cell Gene modification COH
Development Candidate, Proof of Concept
HIV/AIDS Adult Stem Cell Gene-modified, personalized cell therapy CIT
Proof of Concept
Blood Disorders,
Blood Cancer
Adult Stem Cell Small molecule therapy UCLA
Development Candidate
Ovarian Cancer Adult Stem Cell Gene-modified, personalized cell therapy COH
Development Candidate, Proof of Concept
Spina Bifida Adult Stem Cell Donor cell therapy UC Davis
IND
Stroke Adult Stem Cell Gene-modified, donor cell therapy SanBio, Inc.
Clinical Trial, Phase 2
Vision Loss Adult Stem Cell Donor cell therapy Cedars-Sinai
IND
Cystinosis Adult Stem Cell Gene-modified, personalized cell therapy UCSD
IND
Sickle Cell Disease Adult Stem Cell Donor cell therapy COH
Clinical Trial, Phase 1 or Phase 1/2
Skeletal/Smooth Muscle disorders Adult Stem Cell Donor cell therapy UCSF
Proof of Concept
Alpha Thalassemia Major Adult Stem Cell Donor cell therapy UCSF
Clinical Trial, Phase 1 or Phase 1/2
HIV-related Lymphoma,
HIV/AIDS
Adult Stem Cell Gene-modified, personalized cell therapy UC Davis
Clinical Trial, Phase 1 or Phase 1/2

Pages

Icon for csv export